Pharmacokinetic (PK) - pharmacodynamic (PD) study of gemcitabine (G) in a randomised phase II trial of carboplatin (C) combined with G at standard rate infusion or fixed dose rate infusion in patients with advanced non-small-cell lung cancer (NSCLC).

被引：0
|
作者：
Soo, RA
Lim, HL
Wang, LZ
Tham, LS
Soong, R
Lee, HS
Liang, S
Lee, SC
Boyer, M
Goh, BC
机构：
[1] Natl Univ Singapore Hosp, Singapore 117548, Singapore
[2] Natl Univ Singapore, Singapore 117548, Singapore
[3] Clin Trials & Epidemiol Res Unit, Singapore, Singapore
[4] Sydney Canc Ctr, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：141S / 141S
页数：1
相关论文
共 50 条
  • [41] Phase II trial of the novel retinoid, bexarotene, and gemcitabine plus carboplatin in advanced non-small-cell lung cancer
    Edelman, MJ
    Smith, R
    Hausner, P
    Doyle, LA
    Kalra, K
    Kendall, J
    Bedor, M
    Bisaccia, S
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) : 5774 - 5778
  • [42] Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer
    Lilenbaum, RC
    Chen, CS
    Chidiac, T
    Schwarzenberger, PO
    Thant, M
    Versola, N
    Lane, SR
    ANNALS OF ONCOLOGY, 2005, 16 (01) : 97 - 101
  • [43] Phase I-II and pharmacokinetic study of gemcitabine combined with oxaliplatin in patients with advanced non-small-cell lung cancer and ovarian carcinoma
    Faivre, S
    Le Chevalier, T
    Monnerat, C
    Lokiec, R
    Novello, S
    Taieb, J
    Pautier, P
    Lhommé, C
    Ruffié, P
    Kayitalire, L
    Armand, JP
    Raymond, E
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1479 - 1489
  • [44] Biweekly carboplatin and gemcitabine for untreated advanced non-small cell lung cancer (NSCLC). A multicenter phase II trial
    Domine, M
    Gomez, RG
    Firvida, J
    Delgado, J
    Estevez, L
    Docampo, LI
    Leon, A
    Pachon, V
    Casado, V
    Lobo, F
    LUNG CANCER, 2005, 49 : S242 - S242
  • [45] The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer
    Wang, Linrun
    Wu, Xiuhua
    Huang, Mingzhu
    Cai, Jie
    Xu, Nong
    Liu, Jian
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 60 (02) : 211 - 218
  • [46] The efficacy and relationship between peak concentration and toxicity profile of fixed-dose-rate gemcitabine plus carboplatin in patients with advanced non-small-cell lung cancer
    Linrun Wang
    Xiuhua Wu
    Mingzhu Huang
    Jie Cai
    Nong Xu
    Jian Liu
    Cancer Chemotherapy and Pharmacology, 2007, 60 : 211 - 218
  • [47] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas: a GEIS study
    A López-Pousa
    R Losa
    J Martín
    J Maurel
    J Fra
    M Sierra
    A Casado
    J García del Muro
    A Poveda
    C Balañá
    J Martínez-Trufero
    E Esteban
    J M Buesa
    British Journal of Cancer, 2006, 94 : 1797 - 1802
  • [48] Phase I/II trial of doxorubicin and fixed dose-rate infusion gemcitabine in advanced soft tissue sarcomas:: a GEIS study
    Lopez-Pousa, A.
    Losa, R.
    Martin, J.
    Maurel, J.
    Fra, J.
    Sierra, M.
    Casado, A.
    Garcia del Muro, J.
    Poveda, A.
    Balana, C.
    Martinez-Trufero, J.
    Esteban, E.
    Buesa, J. M.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1797 - 1802
  • [49] Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non-Small-cell Lung Cancer
    Schneider, Bryan J.
    Kalemkerian, Gregory P.
    Gadgeel, Shirish M.
    Valdivieso, Manuel
    Hackstock, Deborah M.
    Chen, Wei
    Heilbrun, Lance K.
    Ruckdeschel, John C.
    Wozniak, Antoinette J.
    CLINICAL LUNG CANCER, 2017, 18 (03) : 299 - 302
  • [50] Gemcitabine in brief versus prolonged low-dose infusion, both combined with carboplatin for advanced non-small cell lung cancer
    Beniwal, S. K.
    Patel, K. M.
    Shukla, S.
    Parikh, B. J.
    Shah, S.
    Patel, A.
    INDIAN JOURNAL OF CANCER, 2012, 49 (02) : 202 - 208
12345